University of Miami

University of Miami

University of Miami

Date Founded



McArthur Building,1251 Memorial Drive,Coral Gables, FL 33124-0620

Employees (Worldwide)



Schools & Student Services

Company Description

A private research university with more than 15,000 students from around the world, the University of Miami is a vibrant and diverse academic community focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. Led by President Donna E. Shalala, the University comprises 12 schools and colleges serving undergraduate and graduate students in more than 180 majors and programs. In 2012, U.S.News & World Report ranked UM No. 44 in its “Best Colleges” listings, the fourth year in a row it has been among the top 50, and it continued to be the highest ranked school in Florida. U.S. News also cited several of its programs in “America’s Best Graduate Schools.” Established in 1925 during the region’s famous real estate boom, UM is a major research university engaged in $360 million in research and sponsored program expenditures a year. While the majority of this work is housed at the Miller School of Medicine, investigators conduct dozens of studies in other areas, including marine science, engineering, education, and psychology

Contact Data
Trying to get in touch with decision makers at University of Miami? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Executive Director, Finance & Operations

Chief Executive Officer


Executive Director, Office of Estate & Gift Planning

Executive Director, Intensive English Program

Board of Trustees

Chief Executive Officer at Royal Caribbean Cruises Ltd.

President at American Bar Association

Trustee & Vice Chair at University of Miami

Chairman & Chief Executive Officer at OPKO Health, Inc.

Former Chief Operating Officer & President at Northern Trust Corporation

Founder at The Lois Pope Life Foundation

Former Deputy Managing Partner at Deloitte LLP

Chairman, Second Century Fund at Performing Arts Center Foundation of Greater Miami

Chairman & Chief Executive Officer at MBB Auto LLC

Distinguished Alumni
David A. Siegel is now President, Secretary & Director at CFI Resorts Management, Inc.
Eugene Matthew Schaefer is now President for Miami at Bank of America Corp.
Jeff Benck is now President & Chief Executive Officer at Benchmark Electronics, Inc.
Paths to University of Miami
Potential Connections via
Relationship Science
University of Miami
Transaction Advisors
Legal Advisor

Advised onUniversity of Miami purchases Cedars Healthcare Group Ltd. from HCA, Inc.

Advisors & Consultants

Partner at Latham & Watkins LLP

Real Estate Agent

Founder at Blanca Commercial Real Estate, Inc.


Director of Development at Armory Center for The Arts


Seattle Genetics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in pivotal trial for patients with relapsed or refractory hodgkin lymphoma. The company's other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech; GlaxoSmithKline LLC; MedImmune, Inc.; Millennium; PSMA Development Company LLC; and Genmab A/S. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc. The company was founded in 1998 and is headquartered in Bothell, Washington.

The Consortium for Ocean Leadership Inc., a non-profit organization, represents public and private ocean research and education institutions, aquaria and industry with the mission to advance research, education and sound ocean policy. The organization also manages ocean research and education programs in areas of scientific ocean drilling, ocean observing, ocean exploration, and ocean partnerships. The company was founded in 2007 and is headquartered in Washington, DC.

FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics. It focuses on hypoxia-inducible factor and connective tissue growth factor biology to develop innovative medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.

Key Stats and Financials As of 2016
Market Capitalization
Total Enterprise Value
Earnings Per Share
Non-Profit Donations & Grants Received
Details Hidden

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Durham, NC.

NV5 Global, Inc. Commercial Scientific Research | HOLLYWOOD , FL

NV5 Global, Inc. engages in the provision of professional and technical consulting and certification solutions for public and private sector. It operates through the Infrastructure (INF), and Building, Technology, and Sciences (BTS) segment. The INF segment covers engineering, civil program management, and construction quality assurance practices. The BTS segment includes energy, environmental, and building program management practices. The company was founded on September 12, 2011 and is headquartered in Hollywood, FL.

OHL - Arellano Construction Co. Engineering, Construction & Architecture | Miami, FL

OHL - Arellano Construction Co. provides construction and renovation services. Its product offering includes a comprehensive list of construction and pre-construction services, estimating, scheduling, value engineering as well as selection of equipment and finishes. It works closely with architects, engineers and subcontractors to provide high-quality products and cost-effective options to its clients. The company was founded in 1973 and is headquartered in Miami, FL.

Skanska USA Building, Inc. Engineering, Construction & Architecture | PARSIPPANY, NJ

Skanska USA Building Inc. provides construction, pre-construction consulting, general contracting, design-build and pharmaceutical validation services to the industries including pharmaceutical and biopharmaceutical, educational, high-tech, healthcare, aviation, transportation, sports and entertainment. The company was founded in 2001 and is headquartered in Parsippany, NJ.

Awards & Honors
Rank #124
The Chronicle of Philanthropy - Philanthropy 400
Rank #96
The Chronicle of Philanthropy - Philanthropy 400
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by University of Miami. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of University of Miami's profile does not indicate a business or promotional relationship of any kind between RelSci and University of Miami.
  • be_ixf; php_sdk; php_sdk_1.4.15